Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
about
Clinical and genetic basis of familial amyotrophic lateral sclerosisA Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During DiseaseStable tubule only polypeptides (STOP) proteins co-aggregate with spheroid neurofilaments in amyotrophic lateral sclerosisPlasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALSGenome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis.Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated GenesThe cytoskeleton of digestive epithelia in health and disease.Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-Tooth 2 trigger aggresome formation and neuronal death.A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.The cytoskeleton in neurodegenerative diseases.Genetic rodent models of amyotrophic lateral sclerosisFamilial amyotrophic lateral sclerosis.Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.Therapeutic developments in the treatment of amyotrophic lateral sclerosis.Hereditary motor neuropathies and motor neuron diseases: which is which.Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy.Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin binding and does not affect the actin cytoskeleton.Whole exome sequencing and the clinician: we need clinical skills and functional validation in variant filtering.Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2.2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies.Role of zinc in ALS.Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis.Genetics of amyotrophic lateral sclerosis: an update.Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular VesiclesLive cell imaging of cytoskeletal dynamics in neurons using fluorescence photoactivation.Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin.New therapeutic targets for amyotrophic lateral sclerosis.Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.CSF markers in amyotrophic lateral sclerosis.The genetics and neuropathology of amyotrophic lateral sclerosis.Neurofilament phosphorylation and their proline-directed kinases in health and disease.Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.Neurofilament dynamics and involvement in neurological disorders.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.
P2860
Q26783236-362290E3-EC59-4250-8E39-B07FA92FDE61Q28079299-182457E6-E973-49FE-8F02-B714A722F9CBQ28235829-C9020084-A48C-4B05-A53D-7BCEE4F5AFF2Q28481340-CF746CA9-24D8-4B39-846C-4E49BE35A267Q33501355-405BD3B2-E02C-4185-9403-2EB1F54D3E60Q33576120-9ECD0E31-E960-404C-90AE-E9FF3D8E2081Q33796503-C19B286F-7FC5-48C5-970A-1F2484C563D2Q33909546-7415B060-FB59-4363-8303-216AA1011FCFQ34342425-E6E43C92-C6F9-462D-846F-09E2762DA89BQ34401653-938A8A6F-1993-4850-912B-CC094B3DE07CQ34446779-80A64268-C172-4CF8-AF60-E9D2BC4C3A6DQ34497123-F7DC70F7-0A90-46F8-8513-3151837FCB56Q34547620-5156075D-F637-4FDE-AE84-1BC1C57F7278Q34792280-0FD2D451-DC35-4136-8B40-5FD74110AAB5Q34974850-1597BF9B-F9DF-48E3-9067-BD3D143F850BQ35113116-72F3829B-A87B-400A-AA5E-B13071394EE8Q35425101-769D8CF2-1F8C-42E2-8886-023A6D063975Q35753380-94B19A4D-0B59-4A66-8431-A315FBAF7A4CQ35842667-DCF01B71-AB7A-4AB1-8C73-CD60ABC56D6DQ35856149-91145F90-1F22-4D47-9882-DC0F1AC2239AQ35964723-C95BD443-9EC0-4D0D-B845-025AD1967819Q36337699-BB3507D8-6803-45AF-8790-CB6DBFF0B019Q36381232-21BCBD47-0D13-4F7E-89DB-F4A219FDF5B9Q36419592-EA964BA7-99FB-426A-AE41-CE616BDFCB38Q36835575-62844ED4-B636-4C57-931C-41D5C38C4D1BQ36866600-54513049-091E-41BA-AAB9-3F5AE9096CAFQ37153922-39E4F21B-DB3E-40E1-BFF6-34C5CE9A705DQ37358932-24B74362-12A2-420F-BCBF-E9E18CACEB4DQ37712624-27A7DD58-DFED-4C0C-B2BC-085335499C32Q37724768-D8304389-790A-45FE-A2A7-12E590B5393BQ37739698-956B0C09-8636-4386-9CCD-EE6A9ECBDC61Q37816447-A66225D4-360C-4CE4-9023-C9EF8BF9B2B8Q37959310-5A0DE738-B24A-45CA-9854-B1AD46404FB4Q38007362-FD4ACD71-1BE0-4820-B159-D5EB44FE504DQ38035744-7E5EA4DE-99AC-4801-949C-E6C1455CDDC1Q38070869-7AC3840C-B9C6-4F8B-AAD1-9EA7457883A6Q38075085-1D4E5BEB-B88E-4202-B4AE-94ACB0C3947EQ38131381-34F9308A-8979-4A87-AED6-1AC3754E1142Q38310624-2C5D7916-69F0-4CDC-91FB-3B90999A66C4Q38573829-A3A28F0E-211B-4063-AD99-D56F1D5922BB
P2860
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
description
im Februar 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1999
@uk
name
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@en
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@nl
type
label
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@en
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@nl
prefLabel
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@en
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@nl
P2093
P50
P356
P1476
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
@en
P2093
P304
P356
10.1093/HMG/8.2.157
P577
1999-02-01T00:00:00Z